Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans
- Front Microbiol. 2023 Mar 17:14:1128160. doi: 10.3389/fmicb.2023.1128160.
- 1. Department of Ultrasound Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- 2. Department of Pharmacy, The 960 Hospital of PLA, Jinan, China.
- 3. Department of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
- 4. Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Introduction: Candida albicans is a prevalent opportunistic human Fungal pathogen. However, there are currently very few Antifungal treatments available. Inositol phosphoryl ceramide synthase is an essential and fungal-specific protein that also provides a novel and promising Antifungal target. Aureobasidin A is a widely used inhibitor of inositol phosphoryl ceramide synthase, however the mechanism of resistance to aureobasidin A is largely unknown in pathogenic fungi.
Methods: Here we investigated how C. albicans adapted to low and high concentrations of aureobasidin A.
Results and discussions: We identified trisomy of chromosome 1 as the predominant mechanism of rapid adaptation. Resistance to aureobasidin A was unstable because of the inherent instability of aneuploids. Importantly, chromosome 1 trisomy simultaneously regulated genes which were associated with aureobasidin A resistance that are on this aneuploid chromosome as well as on Other chromosomes. Furthermore, the pleiotropic effect of aneuploidy caused altered resistance not only to aureobasidin A but also to other Antifungal drugs including caspofungin and 5-flucytosine. We posit aneuploidy provides a rapid and reversible mechanism of development of drug resistance and cross resistance in C. albicans.
-
Cat. No.Product NameDescriptionTargetResearch Area
-